Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI
- الموضوع:
- نبذة مختصرة :
Mongolia has one of the highest viral hepatitis infection (B, C, and D) rates in the world. The aims of this study were to increase awareness of this disease and promote viral hepatitis screening in the Mongolian community living in Spain. Through a native community worker, Mongolian adults were invited to a community program consisting of an educational activity, an epidemiological questionnaire, and rapid point-of-care testing for hepatitis B and C. In those testing positive, blood extraction was performed to determine serological and virological parameters. In total, 280 Mongolians were invited to the program and 222 (79%) attended the event: 139 were women (63%), mean age was 42 years, and 78 (35%) had viral hepatitis risk factors. Testing found 13 (5.8%) anti-HCV-positive individuals, 1 with detectable HCV RNA (0.5%), 8 HBsAg-positive (3.6%), and 7 with detectable HBV DNA (3.1%). One additional individual had HBV/HCV co-infection with detectable HBV DNA and HCV RNA. Two subjects had hepatitis B/D co-infection (0.9%). The knowledge questionnaire showed a 1.64/8-point (20.5%) increase in correct answers after the educational activity. In summary, a viral hepatitis community program was feasible and widely accepted. It increased awareness of this condition in the Mongolian community in Spain and led to linkage to care in 22 participants, 50% of whom were unaware of their infection.
- References:
Viruses. 2022 Jul 15;14(7):. (PMID: 35891529)
PLoS One. 2020 Jul 15;15(7):e0235036. (PMID: 32667957)
J Virol Methods. 2021 Mar;289:114039. (PMID: 33338545)
Viruses. 2021 Sep 10;13(9):. (PMID: 34578380)
Vaccines (Basel). 2022 Nov 14;10(11):. (PMID: 36423023)
J Epidemiol. 2007 May;17(3):69-75. (PMID: 17545693)
Semin Liver Dis. 2012 Aug;32(3):228-36. (PMID: 22932971)
BMJ Open Gastroenterol. 2016 Nov 10;3(1):e000119. (PMID: 27933202)
Prev Chronic Dis. 2019 Jan 24;16:E08. (PMID: 30676936)
Rev Esp Salud Publica. 2020 Jul 07;94:. (PMID: 32632084)
Liver Int. 2022 Aug;42(8):1751-1761. (PMID: 35635535)
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):56-58. (PMID: 29201727)
Dig Dis Sci. 2021 Aug;66(8):2833-2839. (PMID: 32770488)
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):57-62. (PMID: 29963464)
- Contributed Indexing:
Keywords: Mongolian community; community program; viral hepatitis awareness; viral hepatitis screening
- الرقم المعرف:
0 (DNA, Viral)
0 (Hepatitis B Surface Antigens)
0 (Hepatitis C Antibodies)
63231-63-0 (RNA)
- الموضوع:
Date Created: 20230729 Date Completed: 20230731 Latest Revision: 20230803
- الموضوع:
20230803
- الرقم المعرف:
PMC10384786
- الرقم المعرف:
10.3390/v15071506
- الرقم المعرف:
37515192
No Comments.